Zoetis to Participate in the 37th Annual J.P. Morgan Healthcare Conference
PARSIPPANY, N.J.--(BUSINESS WIRE)--Dec 18, 2018--Zoetis Inc. (NYSE:ZTS) will participate in the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 9, 2019, in San Francisco, Calif. Juan Ramón Alaix, Chief Executive Officer, will represent the company and respond to questions from analysts. He is scheduled to present at 12:00 p.m. EST (9:00 a.m. PST).
Investors and other interested parties will be able to access a live audio webcast of the presentation by visiting http://investor.zoetis.com/events-presentations. A replay of the presentation will also be available on the Zoetis website at the conclusion of the event.
Zoetis is the leading animal health company, dedicated to supporting its customers and their businesses. Building on more than 60 years of experience in animal health, Zoetis discovers, develops, manufactures and markets medicines, vaccines, and diagnostic products, which are complemented by biodevices, genetic tests and a range of services. Zoetis serves veterinarians, livestock producers and people who raise and care for farm and companion animals with sales of its products in more than 100 countries. In 2017, the company generated annual revenue of $5.3 billion with approximately 9,000 employees. For more information, visit www.zoetis.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20181218005075/en/
KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA NEW JERSEY
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY PHARMACEUTICAL PROFESSIONAL SERVICES BANKING FINANCE VETERINARY GENERAL HEALTH
SOURCE: Zoetis Inc.
Copyright Business Wire 2018.
PUB: 12/18/2018 08:30 AM/DISC: 12/18/2018 08:30 AM